-
9to5Mac: Apple sues OpenAI, accuses ex-employees of stealing trade secrets (Jul. 10, 2026)
Apple sued OpenAI, alleging former employees stole trade secrets by soliciting Apple parts, downloading confidential files, and misleading suppliers. T -
Anthropic: UST is bringing Claude to physical AI (Jul. 9, 2026)
Anthropic and UST are embedding Claude into production systems to automate chip validation, catch faults earlier, and cut iDEC cycle times by up to 70%. -
WSJ: AI Data-Center Construction Is Booming—but Not Much Else Is (Jul. 14, 2026)
Data‑center building is booming (construction spending up 23% year‑over‑year in May) and is masking broader weakness, but data centers make up only about 8% of private nonresidential spending. -
WSJ Opinion: New York’s Data Center Self-Sabotage (Jul. 14, 2026)
Hochul halted new AI data-center permits for a year, citing costs, resource strain, and uncertainty. The pause will cost jobs and taxes, misunderstands evidence that centers can lower rates, and ignores power shortfalls caused by anti–fossil-fuel rules. -
WSJ: America Risks Blowing the AI Race. Here Are Seven Ideas To Get Back on Track. (Jul. 9, 2026)
The U.S. risks losing the AI race to China, despite about $1 trillion in industry investment. It urges a national mobilization: coordinate public, private, and academic efforts. -
WSJ: China Wants More Babies—So It’s Cracking Down on AI Chatbot Love Affairs (Jul. 15, 2026)
China barred companion chatbots from prompting emotional dependence or relationships with minors, and it requires alerts and regulatory review. -
The Chronicle of Higher Education: Data Centers Were Once Boring Pieces of Campus Infrastructure. Now They’re Political Flashpoints. (Jul. 14, 2026)
Colleges planning data centers for AI face strong local opposition over environmental, social, and economic concerns. Universities say centers are needed for research, competitiveness, and partnerships, but protests, petitions, and charges of environmental racism have stalled projects and prompted reviews. -
The Chronicle of Higher Education: Jagged Intelligence: Data center wars come to campuses (Jul. 14, 2026)
Maestro College, rebranded from Peloton, uses AI chatbots to teach, runs on Pell Grants, and raises accreditation, quality concerns. Libraries, scholars, and artists warn AI-generated work threatens research and creativity. -
The Chronicle of Higher Education: How ‘Chaos’ Surrounding AI Can Sink a College Presidency (Jul. 14, 2026)
University of Wisconsin regents, frustrated by President Jay Rothman’s AI presentation and strategy, used texts and emails that helped prompt his firing. -
NY Times: From A.I. to the Deep State, Michel Foucault Foresaw It All (Jul. 10, 2026)
Michel Foucault foresaw issues from authorless A.I. to high-tech surveillance, showing how power shapes language, knowledge, and public life. -
WSJ: Record Companies Push to Label AI Songs on Streaming Platforms (Jul. 10, 2026)
Record labels, artists, and industry groups want streaming services to label AI-generated and AI-assisted music, using two tags for fully AI tracks and human-made tracks using AI. -
NY Times: China, Russia and Others Seek to Inflame Debate Over A.I. Data Centers (Jul. 9, 2026)
China, Russia, and Iran have used state media, and covert social campaigns to inflame U.S. opposition to A.I. data centers, with doctored images, comics, and videos. -
WSJ: The Fight Over Humanoid Robots Has Shut Down a Car Factory for the First Time (Jul. 15, 2026)
Hyundai’s Atlas humanoid robot sparked a partial strike in South Korea, with workers demanding job protections, higher pay, and limits on robot use. Automakers worldwide, including Hyundai, are testing humanoids. -
SiliconANGLE: Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma (Jul. 14, 2026)
Chai Discovery raised $400 million, valuing it at $3.8 billion, and totals about $630 million in funding. Chai-3 doubles success, hits ~35–40%, and has deals with Pfizer, Eli Lilly, and Novartis, but AI drugs still face clinical hurdles. -
WSJ: Alex Karp Is Saying What Every Angry CEO Is Thinking About AI (Jul. 11, 2026)
Palantir CEO Alex Karp accused AI labs of extracting enterprise data value, overcharging customers, and issued a white paper on institutional protections. His comments sparked debate about who captures AI’s value, and raised regulatory, geopolitical, and cost concerns. -
WSJ: U.S. Biotechs Are Keeping More Secrets to Beat Copycats in China (Jul. 9, 2026)
U.S. biotechs are keeping discoveries secret, avoiding investors and conferences, to prevent Chinese rivals from copying work. -
WSJ: Merck’s Cholesterol Pill Lipfendra Approved, Ushering in New Wave of Treatment (Jul. 16, 2026)
The FDA approved Merck’s Lipfendra, the first daily oral PCSK9 pill, which reduces LDL cholesterol by up to 60% beyond statins. It lists at $10.50 per pill, and is being studied for preventing heart attacks and strokes.